Diabetes and depot medroxyprogesterone contraception in Navajo women.

@article{Kim2001DiabetesAD,
  title={Diabetes and depot medroxyprogesterone contraception in Navajo women.},
  author={Catherine Kim and Kenneth W. Seidel and Elizabeth Begier and Yeong S. Kwok},
  journal={Archives of internal medicine},
  year={2001},
  volume={161 14},
  pages={
          1766-71
        }
}
BACKGROUND Depot medroxyprogesterone acetate contraception is widely used in Navajo women, a high-risk population for diabetes mellitus. However, depot medroxyprogesterone may lead to weight gain and independently decrease insulin sensitivity. We studied the association between depot medroxyprogesterone and development of diabetes in Navajo women. METHODS We studied Navajo women aged 18 to 50 years who had seen a health care provider at a Navajo Area Indian Health Service clinic at least once… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis

  • European journal of preventive cardiology
  • 2018
VIEW 9 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Maternal outcomes and follow-up after gestational diabetes mellitus.

  • Diabetic medicine : a journal of the British Diabetic Association
  • 2014

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Diabetes Prevalence Rates by Service Unit

E Espey, J Steinhart, T Ogburn, C Qualls
  • 2000

Diabetes Prevalence Rates by Service Unit. Window Rock, Ariz: Office of Program Planning and Evaluation, Navajo Area Indian Health

M. Everett
  • 2000
VIEW 1 EXCERPT

Navajo Nation; 1994:130

D. Etsitty
  • Navajo Nation Fax ’93
  • 1999
VIEW 2 EXCERPTS

Task Force

US Preventive Service
  • Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing Inc;
  • 1996
VIEW 1 EXCERPT